2023 Annual Meeting | H182 - Championing Quality Improvement in Academia (Practice and Policy Hub)

��ɫ��

2023 Annual Meeting | H182 - Championing Quality Improvement in Academia (Practice and Policy Hub)

Date Monday 04/24/23

Time 04:00 PM - 04:30 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Hubs (Practice and Policy)

Director(s) K. H. Vincent Lau, MD, Michelle Kaku, MD

Topic(s) Practice, Policy, and Ethics

Learning Objectives This Practice and Policy Hub is designed to educate academic neurologists about ways to champion quality improvement (QI) at their institutions. Participant to this session should gain insights on how to design and lead morbidity and mortality conferences, institute and maintain error-reporting systems, and lead QI research and dissemination efforts.

CME Available 0.50 CME credit

Core Competencies Interpersonal and Communication Skills, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement

Program Level Introductory

Program Tracks Business of Neurology, Academic

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic

Event Timeline
04:00 PM - 04:30 PM EST	Speaker	Championing Quality Improvement in Academia K. H. Vincent Lau, MD, Michelle Kaku, MD

Faculty Disclosures
K. H. Vincent Lau, MD	Dr. Lau has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Dr. Lau has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for mctlaw. Dr. Lau has stock in Alnylam Pharmaceuticals.
Michelle Kaku, MD	Dr. Kaku has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Fatcliffe Harten Galamaga LLP.

��ɫ����

��ɫ����

��ɫ��

��ɫ��